• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[冠心病与脂蛋白(a):与其他脂质心血管危险因素的关系]

[Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].

作者信息

Nogués X, Sentí M, Pedro-Botet J, Molina L, Serrat R, Pons S, Rubiés-Prat J

机构信息

Departamento de Medicina del Hospital del Mar, Barcelona.

出版信息

Med Clin (Barc). 1992 Feb 8;98(5):171-4.

PMID:1532436
Abstract

BACKGROUND

Lipoprotein (Lp) (a) is considered a risk factor for early coronary heart disease (CHD), and a discriminant cutoff of Lp(a) concentration has been suggested.

METHODS

Serum Lp(a) concentrations have been determined by enzymoimmunoassay in 66 men with CHD and in 100 healthy control men. Serum cholesterol, serum triglycerides, high density lipoprotein (HDL)-cholesterol, and apoprotein (apo) A-I were also determined.

RESULTS

Serum Lp(a) concentration was 21.7 +/- 16.9 mg/dl (mean +/- SD) in patients and 12.5 +/- 12.5 mg/dl in controls (p less than 0.001). Serum cholesterol was 5.63 +/- 1.22 mmol/l and 5.29 +/- 1.00 mmol/l (p less than 0.05) respectively; serum triglycerides were 1.99 +/- 1.23 mmol/l and 1.29 +/- 0.61 mmol/l (p less than 0.001) respectively; HDL-cholesterol was 0.97 +/- 0.27 mmol/l and 1.07 +/- 0.30 mmol/l (p less than 0.05) respectively; and apo A-I was 94 +/- 15 mg/dl and 144 +/- 41 mg/dl (p less than 0.001) respectively. Lp(a) concentrations were not correlated with other well-recognized cardiovascular risk lipidic factors, nor influenced by age either body mass index. Using 20 mg/dl as discriminant Lp(a) concentration between patients and controls, a ratio 2:1 in patients with respect to controls has been observed and exceeded some more when the threshold level was put on 30 mg/dl. A subset of normocholesterolemic and normotriglyceridemic patients (n = 17) and controls (n = 49) had serum Lp(a) concentration of 22.7 +/- 16.3 mg/dl and 9.1 +/- 8.2 mg/dl (p less than 0.001) respectively.

CONCLUSIONS

Increased concentration of Lp(a) constitutes an independent risk factor for CHD. On the other hand, Lp(a) concentrations of 20 mg/dl or 30 mg/dl as risk threshold levels are well-defined.

摘要

背景

脂蛋白(a)[Lp(a)]被认为是早期冠心病(CHD)的一个危险因素,并且有人提出了Lp(a)浓度的判别临界值。

方法

采用酶免疫分析法测定了66例冠心病男性患者和100例健康对照男性的血清Lp(a)浓度。同时还测定了血清胆固醇、血清甘油三酯、高密度脂蛋白(HDL)胆固醇和载脂蛋白(apo)A-I。

结果

患者血清Lp(a)浓度为21.7±16.9mg/dl(均值±标准差),对照组为12.5±12.5mg/dl(p<0.001)。血清胆固醇分别为5.63±1.22mmol/l和5.29±1.00mmol/l(p<0.05);血清甘油三酯分别为1.99±1.23mmol/l和1.29±0.61mmol/l(p<0.001);HDL胆固醇分别为0.97±0.27mmol/l和1.07±0.30mmol/l(p<0.05);apo A-I分别为94±15mg/dl和144±41mg/dl(p<0.001)。Lp(a)浓度与其他公认的心血管危险因素脂质无关,也不受年龄和体重指数的影响。以20mg/dl作为患者与对照组之间Lp(a)浓度的判别值时,观察到患者与对照组的比例为2:1,当阈值提高到30mg/dl时,该比例更高。一组血脂正常的患者(n=17)和对照组(n=49)的血清Lp(a)浓度分别为22.7±16.3mg/dl和9.1±8.2mg/dl(p<0.001)。

结论

Lp(a)浓度升高是冠心病的一个独立危险因素。另一方面,20mg/dl或30mg/dl的Lp(a)浓度作为危险阈值水平是明确的。

相似文献

1
[Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].[冠心病与脂蛋白(a):与其他脂质心血管危险因素的关系]
Med Clin (Barc). 1992 Feb 8;98(5):171-4.
2
Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.中国人群中载脂蛋白(a)表型、脂蛋白(a)浓度及血脂水平与冠心病的关系:载脂蛋白(a)基因在冠心病中作用的证据
J Clin Invest. 1992 Mar;89(3):1040-6. doi: 10.1172/JCI115645.
3
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.冠心病男性患者弥漫性动脉粥样硬化的相关因素及后果。退伍军人事务部高密度脂蛋白干预试验研究组。
Arch Intern Med. 1996 Jun 10;156(11):1181-8.
4
Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.血清脂蛋白(a)浓度升高对2型糖尿病患者冠心病风险的影响。
Metabolism. 2008 Jun;57(6):791-5. doi: 10.1016/j.metabol.2008.01.020.
5
[Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].早期缺血性心脏病患者以及有缺血性心脏病家族史的患者体内脂蛋白(a)水平升高。
Minerva Med. 1999 May-Jun;90(5-6):151-8.
6
The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.肾脏替代治疗的改变对血清脂蛋白(a)浓度的影响。
Adv Perit Dial. 1997;13:168-73.
7
Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.法裔加拿大人早发性冠状动脉疾病中的代谢因素聚集、脂蛋白胆固醇、载脂蛋白B、脂蛋白(a)和载脂蛋白E表型
Can J Cardiol. 1997 Mar;13(3):253-60.
8
Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.银屑病患者中的脂蛋白(a):与血脂谱及疾病严重程度的关联。
Int J Dermatol. 2009 Apr;48(4):379-87. doi: 10.1111/j.1365-4632.2009.03994.x.
9
[Plasma levels of lipids, lipoproteins and apolipoproteins affected by endogenous testosterone].
Hunan Yi Ke Da Xue Xue Bao. 1998;23(3):299-301.
10
Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.透析类型对血清脂质、载脂蛋白和脂蛋白的影响。
Ren Fail. 2006;28(7):567-71. doi: 10.1080/08860220600839761.